Myotonic Dystrophy Type 1: Focus on the RNA Pathology and Therapy

QR Code

Myotonic Dystrophy Type 1: Focus on the RNA Pathology and Therapy

None

Saved in:

Bibliographic Details
Main Authors:	Mastroyiannopoulos, Nikolaos P., Koutsoulidou, Andrie, Phylactou, Leonidas A.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/36749
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cardiac manifestations in myotonic dystrophy type 1
by: A. G. Klementieva, et al.
Published: (2024-09-01)

Myotonic Dystrophy Type 1 (DM1): From the Genetics to Molecular Mechanisms
by: Magaña, Jonathan J., et al.
Published: (2012)

Evaluation of echocardiography monitoring in myotonic dystrophy type 1 patients
by: D. S. H. Bovenkerk, et al.
Published: (2025-07-01)

Clinical characteristics of different forms of myotonic dystrophy type 1
by: E. K. Erokhina, et al.
Published: (2023-06-01)

Cognitive and emotional disturbances in adult patients with myotonic dystrophy type 1
by: E. K. Erokhina, et al.
Published: (2024-05-01)

Myotonic dystrophy type 1 and oxidative imbalance: evaluation of ischemia-modified albumin and oxidant stress
by: Sertpoyraz Filiz Meryem, et al.
Published: (2025-04-01)

Thymoma-associated myasthenia gravis coexisting with myotonic dystrophy: a case report
by: Michiyo Miyawaki, et al.
Published: (2021-07-01)

Stem Cell Based Therapy for Muscular Dystrophies: Cell Types and Environmental Factors Influencing Their Efficacy
by: Morgan, Jennifer, et al.
Published: (2012)

Genetic Therapy for Duchenne Muscular Dystrophy: Principles and Progress
by: Koo, Taeyoung, et al.
Published: (2012)

Duchenne Muscular Dystrophy: Experimental models on Physical Therapy
by: Gaiad, Thais, et al.
Published: (2012)

Clinical and electromyographic criteria for the diagnosis of hereditary myotonic syndromes
by: V. P. Fedotov, et al.
Published: (2015-02-01)

Diagnosis of the Muscular Dystrophies
by: Waddell, Leigh B., et al.
Published: (2012)

Etiopathology of Type 1 Diabetes: Focus on the Vascular Endothelium
by: Liuba, Petru, et al.
Published: (2011)

Progress and Challenges in AAV-Mediated Gene Therapy for Duchenne Muscular Dystrophy
by: Takeda, Shin'Ichi, et al.
Published: (2011)

Pathologic Significance of EBV Encoded RNA in NPC
by: Li, Zhi, et al.
Published: (2012)

Myotonia and myotonic discharges of dystrophic myotonia type 1 at the first decade onset: a literature review and data of the case series
by: S. A. Kurbatov, et al.
Published: (2022-06-01)

Duchenne Muscular Dystrophy and Brain Function
by: Anderson, J.L., et al.
Published: (2012)

Rehabilitation in Muscular Dystrophies: Changing Approach
by: Groot, Imelda J.M. de, et al.
Published: (2012)

Advances in Molecular Analysis of Muscular Dystrophies
by: Ankala, Arunkanth, et al.
Published: (2012)

Database of Wards for Patients with Muscular Dystrophy in Japan
by: Saito, Toshio, et al.
Published: (2012)

Strength and Functional Measurement for Patients with Muscular Dystrophy
by: Lu, Yen-Mou, et al.
Published: (2012)

Muscle Satellite Cells and Duchenne Muscular Dystrophy
by: Miyagoe-Suzuki, Yuko, et al.
Published: (2012)

RNA Interference for Tumor Therapy
by: Xia, Wei, et al.
Published: (2012)

Assessment quality of life as a factor for the improvement of patient-focused therapy of the preschool children with type 1 diabetes
by: I. L. Nikitina, et al.
Published: (2022-01-01)

Myotonic dystrophy-related CDC42-binding kinase alpha (MRCKα) mediates methionine- and leucine-stimulated β-casein synthesis in bovine mammary epithelial cells via targeting mTOR
by: Fang Wang, et al.
Published: (2025-06-01)

AON-Mediated Exon Skipping for Duchenne Muscular Dystrophy
by: Verhaart, Ingrid E. C., et al.
Published: (2012)

Abnormal Ion Homeostasis and Cell Damage in Muscular Dystrophy
by: Iwata, Yuko, et al.
Published: (2012)

Altered Gene Expression Pathways in Duchenne Muscular Dystrophy
by: Juretić, Nevenka, et al.
Published: (2012)

Duchenne Muscular Dystrophy: Therapeutic Approaches to Restore Dystrophin
by: Spitali, Pietro, et al.
Published: (2012)

Perspectives of Cell Therapy in Type 1 Diabetes
by: Zanone, Maria M., et al.
Published: (2011)

EYE PATHOLOGIES IN FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (CASE REPORT AND LITERARY ANALYSIS)
by: E. V. Denisova, et al.
Published: (2018-10-01)

Psychosocial Support Needs of Families of Boys with Duchenne Muscular Dystrophy
by: Mah, Jean K., et al.
Published: (2012)

Nuclear Poly (A)-Binding Protein and Oculopharyngeal Muscular Dystrophy
by: Bag, Jnanankur, et al.
Published: (2012)

Refractory Angina Pectoris: Focus on Cell Therapy
by: Pompilio, Giulio, et al.
Published: (2011)

Renal Cell Carcinoma in Dialysis Patients with End Stage Renal Disease: Focus on Surgery and Pathology
by: Masuda, Hitoshi, et al.
Published: (2011)

Facioscapulohumeral Muscular Dystrophy: From Clinical Data to Molecular Genetics and Return
by: Salani, Monica, et al.
Published: (2012)

MicroRNA (miRNA) Regulation in Glioma: Implications in Development, Progression, Grading, Prognosis and Therapy
by: Somasundaram, Kumaravel, et al.
Published: (2011)

Alzheimer’s Disease and Type 2 Diabetes: Different Pathologies and Same Features
by: Carlo, Marta Di, et al.
Published: (2011)

Chitosan-DNA/siRNA Nanoparticles for Gene Therapy
by: Shi, Qin, et al.
Published: (2011)

Modern aspects of therapy of primary and secondary dystrophies of the cornea
by: E. S. Vakhova, et al.
Published: (2018-10-01)